Playback speed
10 seconds
ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. SBRT Followed by Sorafenib in Advanced HCC
By
ASCO GI 2023 Conference Coverage
FEATURING
Laura Dawson
By
ASCO GI 2023 Conference Coverage
FEATURING
Laura Dawson
442 views
February 6, 2023
Comments 0
Login to view comments.
Click here to Login